Both ccRCC and SKCM exhibit exogenous cholesterol dependent metabolic fragility, and targeting SCARB1, which mediates their main source of cholesterol, may aid in their diagnosis and accurate treatment. Here, SCARB1 is linked to nonpapillary renal cell carcinoma.